Impact  	Impact  	 NN	O
of  	of  	 IN	O
Avène  	Avène  	 NNP	B-NP
hydrotherapy  	hydrotherapy  	 NN	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life  	life  	 NN	O
of  	of  	 IN	O
atopic  	atopic  	 NN	B-NP
and  	and  	 CC	O
psoriatic  	psoriatic  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
Atopic  	Atopic  	 JJ	I-NP
dermatitis  	dermatitis  	 NN	I-NP
and  	and  	 CC	O
psoriasis  	psoriasis  	 NNS	B-NP
engender  	engender  	 VBP	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
deterioration  	deterioration  	 NN	B-NP
in  	in  	 IN	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life 	life 	 NN	O
.  	.  	 .	O
Although  	Although  	 IN	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
patient  	patient  	 JJ	O
management  	management  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
Avène  	Avène  	 JJ	B-NP
hydrotherapy  	hydrotherapy  	 JJ	I-NP
centre  	centre  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
demonstrated  	demonstrated  	 VBN	O
by  	by  	 IN	O
clinical  	clinical  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
few  	few  	 JJ	O
data  	data  	 NNS	O
relating  	relating  	 VBG	O
to  	to  	 TO	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life  	life  	 NN	O
following  	following  	 VBG	O
therapeutic  	therapeutic  	 JJ	B-NP
management  	management  	 NN	I-NP
are  	are  	 VBP	O
available 	available 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
short-  	short-  	 JJ	O
and  	and  	 CC	O
medium-term  	medium-term  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	O
hydrotherapy  	hydrotherapy  	 VBG	O
not  	not  	 RB	O
only  	only  	 RB	O
on  	on  	 IN	O
the  	the  	 DT	O
patients 	patients 	 NNS	O
'  	'  	 POS	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life 	life 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
on  	on  	 IN	O
the  	the  	 DT	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life  	life  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
parents  	parents  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
treated  	treated  	 JJ	O
children 	children 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
6-month  	6-month  	 JJ	O
longitudinal  	longitudinal  	 JJ	B-NP
observational  	observational  	 JJ	I-NP
study 	study 	 NN	I-NP
,  	,  	 ,	O
adult  	adult  	 NN	B-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
174 	174 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
paediatric  	paediatric  	 NNS	B-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
212 	212 	 CD	O
)  	)  	 -RRB-	O
atopic  	atopic  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
and  	and  	 CC	O
psoriatic  	psoriatic  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
262 	262 	 CD	O
)  	)  	 -RRB-	O
had  	had  	 VBD	O
to  	to  	 TO	O
complete  	complete  	 VB	O
questionnaires  	questionnaires  	 VBN	O
relating  	relating  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life  	life  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
beginning  	beginning  	 NN	O
( 	( 	 -LRB-	O
D0 	D0 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
after  	after  	 IN	O
3  	3  	 CD	O
weeks  	weeks  	 NNS	O
hydrotherapy  	hydrotherapy  	 VBP	O
( 	( 	 -LRB-	O
W3 	W3 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
then 	then 	 RB	O
,  	,  	 ,	O
3  	3  	 CD	O
( 	( 	 -LRB-	O
M3 	M3 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
6  	6  	 CD	O
months  	months  	 NNS	O
( 	( 	 -LRB-	O
M6 	M6 	 NNP	O
)  	)  	 -RRB-	O
later 	later 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
dermatology  	dermatology  	 JJ	B-NP
life  	life  	 NN	I-NP
quality  	quality  	 NN	I-NP
index  	index  	 NN	I-NP
( 	( 	 -LRB-	O
DLQI 	DLQI 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
Short-Form-12  	Short-Form-12  	 NNP	B-NP
Health  	Health  	 NNP	I-NP
Survey  	Survey  	 NNP	I-NP
( 	( 	 -LRB-	O
SF-12 	SF-12 	 NNP	B-NP
)  	)  	 -RRB-	O
generic  	generic  	 JJ	B-NP
questionnaire  	questionnaire  	 NN	I-NP
were  	were  	 VBD	O
given  	given  	 VBN	O
to  	to  	 TO	O
adult  	adult  	 VB	O
patients 	patients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
children 	children 	 NNS	B-NP
's  	's  	 POS	I-NP
dermatological  	dermatological  	 JJ	I-NP
life  	life  	 NN	I-NP
quality  	quality  	 NN	I-NP
index  	index  	 NN	I-NP
( 	( 	 -LRB-	O
CDLQI 	CDLQI 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
given  	given  	 VBN	O
to  	to  	 TO	O
paediatric  	paediatric  	 VB	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
SF-12  	SF-12  	 NN	B-NP
to  	to  	 TO	O
their  	their  	 PRP$	O
parents 	parents 	 NNS	O
.  	.  	 .	O
At  	At  	 IN	O
D0 	D0 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
DLQI  	DLQI  	 NNP	B-NP
score  	score  	 NN	I-NP
was  	was  	 VBD	O
29.7  	29.7  	 CD	O
±  	±  	 CD	O
20.1  	20.1  	 CD	O
and  	and  	 CC	O
26.9  	26.9  	 CD	O
±  	±  	 CD	O
18.9  	18.9  	 CD	O
for  	for  	 IN	O
atopic  	atopic  	 NN	B-NP
and  	and  	 CC	O
psoriatic  	psoriatic  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
At  	At  	 IN	O
W3 	W3 	 NNP	O
,  	,  	 ,	O
this  	this  	 DT	O
score  	score  	 NN	O
had  	had  	 VBD	O
decreased  	decreased  	 VBN	O
significantly  	significantly  	 RB	O
to  	to  	 TO	O
reach  	reach  	 VB	O
16.8  	16.8  	 CD	O
±  	±  	 CD	O
14.9  	14.9  	 CD	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.01 	0.01 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
10.0  	10.0  	 CD	O
±  	±  	 CD	O
10.5  	10.5  	 CD	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.001 	0.001 	 NNP	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
atopic  	atopic  	 NN	B-NP
and  	and  	 CC	O
psoriatic  	psoriatic  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
DLQI  	DLQI  	 NNP	B-NP
scores  	scores  	 NNS	I-NP
at  	at  	 IN	O
M3  	M3  	 NNP	O
and  	and  	 CC	O
M6  	M6  	 NNP	O
were  	were  	 VBD	O
20.7  	20.7  	 CD	O
±  	±  	 CD	O
16.4  	16.4  	 CD	O
and  	and  	 CC	O
23.1  	23.1  	 CD	O
±  	±  	 CD	O
18.8  	18.8  	 CD	O
for  	for  	 IN	O
atopic  	atopic  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
and  	and  	 CC	O
18.8  	18.8  	 CD	O
±  	±  	 CD	O
16.7  	16.7  	 CD	O
and  	and  	 CC	O
21.9  	21.9  	 CD	O
±  	±  	 CD	O
19.6  	19.6  	 CD	O
for  	for  	 IN	O
psoriatic  	psoriatic  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
and  	and  	 CC	O
remained  	remained  	 VBD	O
significantly  	significantly  	 RB	O
lower  	lower  	 JJR	O
in  	in  	 IN	O
comparison  	comparison  	 NN	O
with  	with  	 IN	O
D0  	D0  	 CD	B-NP
values  	values  	 NNS	I-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
A  	A  	 DT	O
3-week  	3-week  	 JJ	O
course  	course  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
Avène  	Avène  	 JJ	B-NP
hydrotherapy  	hydrotherapy  	 NNS	I-NP
centre  	centre  	 VBP	O
significantly  	significantly  	 RB	O
improved  	improved  	 VBN	O
the  	the  	 DT	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life  	life  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
suffering  	suffering  	 VBG	O
from  	from  	 IN	O
skin  	skin  	 NN	O
diseases 	diseases 	 NNS	O
.  	.  	 .	O
This  	This  	 DT	O
improvement  	improvement  	 NN	O
persisted  	persisted  	 VBD	O
3  	3  	 CD	O
and  	and  	 CC	O
6  	6  	 CD	O
months  	months  	 NNS	O
after  	after  	 IN	O
management  	management  	 NN	O
by  	by  	 IN	O
hydrotherapy 	hydrotherapy 	 NN	B-NP
.  	.  	 .	O
